Tardive dyskinesia – how is it prevented and treated?
| Autor: | Denise Duncan, David Taylor, H W McConnell |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Pediatrics
medicine.medical_specialty business.industry medicine.medical_treatment Tardive dyskinesia medicine.disease 030227 psychiatry 03 medical and health sciences Psychiatry and Mental health 0302 clinical medicine medicine 030212 general & internal medicine business Antipsychotic Chlorpromazine medicine.drug |
| Zdroj: | Psychiatric Bulletin. 21:422-425 |
| ISSN: | 1472-1473 0955-6036 |
| DOI: | 10.1192/pb.21.7.422 |
| Popis: | Tardive dyskinesia (TD), literally meaning a late occurring, abnormal movement disorder, was first described by Schonecker in 1957, about five years after the discovery of chlorpromazine (cited in Kane, 1992). TD generally occurs after long-term antipsychotic therapy: Kane et al (1984) reported that the incidence was increased with each subsequent year of exposure to antipsychotics, starting with an incidence of 5% after one year of exposure and increasing by 5% each subsequent year. Certainly, the prevalence of TD has increased over the last 20 years, probably as the result of more patients being exposed to antipsychotics for longer periods. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|